0001179110-12-016092.txt : 20121115
0001179110-12-016092.hdr.sgml : 20121115
20121115150332
ACCESSION NUMBER: 0001179110-12-016092
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20121113
FILED AS OF DATE: 20121115
DATE AS OF CHANGE: 20121115
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IMMUNOGEN INC
CENTRAL INDEX KEY: 0000855654
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 042726691
STATE OF INCORPORATION: MA
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 830 WINTER ST
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: (781)895-0600
MAIL ADDRESS:
STREET 1: 830 WINTER ST
CITY: WALTHAM
STATE: MA
ZIP: 02451
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SKALETSKY MARK B
CENTRAL INDEX KEY: 0001073379
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-17999
FILM NUMBER: 121208420
MAIL ADDRESS:
STREET 1: 1896 RUTHERFORD ROAD
CITY: CARLSBAD
STATE: CA
ZIP: 92008
4
1
edgar.xml
FORM 4 -
X0306
4
2012-11-13
0
0000855654
IMMUNOGEN INC
IMGN
0001073379
SKALETSKY MARK B
22 PURITAN ROAD
NEWTON
MA
02461
1
0
0
0
Deferred Share Unit
0
2012-11-13
4
A
0
2626
0
A
2013-02-01
Common Stock
2626
2626
D
Stock option (right to buy)
11.42
2012-11-13
4
A
0
4645
11.42
A
2013-02-01
2022-11-13
Common Stock
4645
4645
D
The deferred share units were issued pursuant to the Issuer's Compensation Policy for Non-Employee Directors and are convertible into Common Stock on a one-to-one basis.
The vested deferred share units are to be settled 100% in shares of Common Stock of the Company upon the reporting person's retirement from the Board of Directors.
The deferred share units vest ratably over a one year period in quarterly increments beginning on February 1, 2013, contingent upon the individual remaining a director as of each vesting date.
Exercisable as to 1,162 shares commencing on February 1, 2013, 1,161 shares commencing on May 1, 2013, 1,161 shares commencing on August 1, 2013 and 1,161 shares commencing on November 1, 2013, contingent upon the individual remaining a director as of each vesting date.
/s/ Craig Barrows, attorney in fact
2012-11-15